Amplyx was founded on a mission to save lives by developing a new class of antifungal medicine that would overcome the severe limitations of today’s therapeutic options. We are developing first-in-class products for the treatment of life-threatening infections, with a near-term focus on deadly fungal pathogens in vulnerable, immune-compromised patients. Amplyx’s leadership has extensive experience developing drugs to treat infectious diseases, as well as treatments for rare conditions.
For more information on Amplyx, please visit our website at www.amplyx.com
Location: United States, California, San Diego
Member count: 11-50
Total raised: $207.7M
Investors 8
Funding Rounds 5
| Date | Series | Amount | Investors | Deal News |
| 20.05.2020 | Series C | $90M | Sofinnova ... | finsmes.co... |
| 02.08.2017 | Series C | $67M | New Enterp... | socaltech.... |
| 09.02.2016 | - | $8.7M | - | finsmes.co... |
| 11.11.2015 | Series B | $40.5M | - | finsmes.co... |
| 09.04.2010 | - | $1.5M | - | socaltech.... |
Mentions in press and media 23
| Date | Title | Description | Category | Author | Source |
| 03.12.2020 | Amplyx Ann... | SAN DIEGO, Dec. 3, 2020 /PRN... | - | - | prnewswire... |
| 06.11.2020 | Covid-19 r... | A major player trying to ad... | - | Max Gelman... | endpts.com... |
| 20.05.2020 | Amplyx clo... | - | - | - | arixbiosci... |
| 19.05.2020 | Amplyx... | San Diego-based Amplyx Pharmac... | - | - | socaltech.... |
| 19.05.2020 | Amplyx Pha... | Amplyx Pharmaceuticals, a San ... | USA | - | finsmes.co... |
| 19.05.2020 | Immune The... | - | - | - | connect.or... |
| 17.09.2019 | Amgen ink... | → Amgen has enlisted Hummi... | - | Endpoints ... | endpts.com... |
| 03.08.2017 | Term Sheet... | MARKDOWNS AGAIN After we wrot... | - | - | fortune.co... |
| 02.08.2017 | Amplyx... | San Diego-based Amplyx Pharmac... | - | - | socaltech.... |
| 02.08.2017 | Amplyx Pha... | SAN DIEGO, CA, Company devel... | - | - | vcnewsdail... |
Show more